Background. The current proposal is a competitive renewal application that focuses on defining the mechanisms causing zonation of the adrenal cortex. In the mammalian adrenal cortex, mineralocorticoids are produced in the zona glomerulosa (ZG) and glucocorticoids in the zona fasciculata (ZF). Production of aldosterone results from ZG-specific expression of the enzyme aldosterone synthase (Cyp11b2), while production of glucocorticoids relies on ZF-specific expression of the closely related 11?-hydroxylase (Cyp11b1). In normal physiology, the aldosterone production in the ZG is tightly regulated by the renin-angiotensin II system. However, dysregulation of zonation with renin-independent aldosterone production and Cyp11b2 expression occurs in primary aldosteronism (PA), a condition that affects 8% of hypertensive patients. The current proposal takes advantage of our past molecular research on Cyp11b2 and moves our findings into in vivo models of mammalian zonation and adrenal disease. Research goals.
Specific Aim 1 will define the contribution of Dax1 (Nr0b1) in normal adrenocortical zonation. Hypothesis for Aim 1: Dax1 expression is required for adrenal zone-specific Cyp11b2 and Cyp11b1 expression. Approach for Aim 1: Cell and mouse based approaches will be used to define the interplay between Sf1 and Dax1 in the regulation of adrenal cell production of aldosterone (ZG phenotype) vs. corticosterone (ZF phenotype). Primary cultures of mouse adrenal cells and the H295R human adrenocortical cell line will be used to define the molecular mechanisms by which Sf1 and Dax1 cooperatively regulate gene expression that defines ZG versus ZF steroid production. Mouse genetic models will be used to interrogate the sexual dimorphic roles of Dax1 in adrenal zonation and corresponding ZG Cyp11b2 versus ZF Cyp11b1 expression.
Specific Aim 2 will define mechanisms responsible for sex differences in adrenal aldosterone production and susceptibility to PA. Hypothesis for Aim 2: The differential expression of the nuclear receptor Dax1 in female vs male adrenals directly impacts Cyp11b2 expression, aldosterone production, and susceptibility to PA. Rationale for Aim 2: Four mouse models of PA have shown greater disease susceptibility in females compared to males. In addition, women have a higher prevalence of low renin hypertension and a higher aldosterone/renin ratio compared to men. The molecular mechanisms controlling these differences are not known. Physiological manipulations and transgenic mouse experiments are proposed to test hypotheses associated with both project aims. Innovations. There are at least three key innovative components to the proposed research: 1) This will represent the first development of an inducible mouse model of PA; 2) First research designed to define the role for sexual dimorphism in adrenal zonation and PA; 3) First to apply broad based LC-MS/MS determination of steroids (30 steroids) to define the steroid metabolome of male and female mice. Significance: The proposed studies will provide a detailed understanding of the molecular mechanisms responsible for adrenal functional zonation (ZG vs ZF) and the mechanisms leading to PA.
The adrenal cortex is physically divided into functionally distinct zones. The outer adrenal glomerulosa zone produces mineralocorticoids and the inner fasciculata zone produces glucocorticoids. Disruption of this zonation is a key feature in progression of adrenal disease. We recently defined a series of sex-differences in the adrenal zones that alter male and female susceptibility to the adrenal disease, primary aldosteronism. In the proposed research, we will define the molecular mechanisms causing sex-differences in adrenal mineralocorticoid production and susceptibility to primary aldosteronism. In addition, we will define the mechanisms causing male and female adrenals to release distinct steroid hormones.
| Omata, Kei; Satoh, Fumitoshi; Morimoto, Ryo et al. (2018) Cellular and Genetic Causes of Idiopathic Hyperaldosteronism. Hypertension 72:874-880 |
| Rege, Juilee; Turcu, Adina F; Kasa-Vubu, Josephine Z et al. (2018) 11-Ketotestosterone Is the Dominant Circulating Bioactive Androgen During Normal and Premature Adrenarche. J Clin Endocrinol Metab 103:4589-4598 |
| Gomez-Sanchez, Celso E; Lewis, Mark; Nanba, Kazutaka et al. (2017) Development of monoclonal antibodies against the human 3?-hydroxysteroid dehydrogenase/isomerase isozymes. Steroids 127:56-61 |
| Nanba, Kazutaka; Chen, Andrew X; Omata, Kei et al. (2016) Molecular Heterogeneity in Aldosterone-Producing Adenomas. J Clin Endocrinol Metab 101:999-1007 |
| Rege, Juilee; Karashima, Shigehiro; Lerario, Antonio M et al. (2016) Age-dependent Increases in Adrenal Cytochrome b5 and Serum 5-Androstenediol-3-sulfate. J Clin Endocrinol Metab 101:4585-4593 |
| Rege, Juilee; Nishimoto, Hiromi Koso; Nishimoto, Koshiro et al. (2015) Bone Morphogenetic Protein-4 (BMP4): A Paracrine Regulator of Human Adrenal C19 Steroid Synthesis. Endocrinology 156:2530-40 |
| Nanba, Kazutaka; Chen, Andrew; Nishimoto, Koshiro et al. (2015) Role of Ca(2+)/calmodulin-dependent protein kinase kinase in adrenal aldosterone production. Endocrinology 156:1750-6 |
| Nishimoto, Koshiro; Tomlins, Scott A; Kuick, Rork et al. (2015) Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands. Proc Natl Acad Sci U S A 112:E4591-9 |
| Monticone, Silvia; Else, Tobias; Mulatero, Paolo et al. (2015) Understanding primary aldosteronism: impact of next generation sequencing and expression profiling. Mol Cell Endocrinol 399:311-20 |
| Chen, Andrew X; Nishimoto, Koshiro; Nanba, Kazutaka et al. (2015) Potassium channels related to primary aldosteronism: Expression similarities and differences between human and rat adrenals. Mol Cell Endocrinol 417:141-8 |
Showing the most recent 10 out of 45 publications
